These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18243138)

  • 21. Effect of estrogen on bone resorption and inflammation in the temporomandibular joint cellular elements.
    Galal N; El Beialy W; Deyama Y; Yoshimura Y; Yoshikawa T; Suzuki K; Totsuka Y
    Int J Mol Med; 2008 Jun; 21(6):785-90. PubMed ID: 18506373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coculture of osteoclast precursors with rheumatoid synovial fibroblasts induces osteoclastogenesis via transforming growth factor beta-mediated down-regulation of osteoprotegerin.
    Hase H; Kanno Y; Kojima H; Sakurai D; Kobata T
    Arthritis Rheum; 2008 Nov; 58(11):3356-65. PubMed ID: 18975335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naringenin inhibits human osteoclastogenesis and osteoclastic bone resorption.
    La VD; Tanabe S; Grenier D
    J Periodontal Res; 2009 Apr; 44(2):193-8. PubMed ID: 18705650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolactin decreases expression of Runx2, osteoprotegerin, and RANKL in primary osteoblasts derived from tibiae of adult female rats.
    Charoenphandhu N; Teerapornpuntakit J; Methawasin M; Wongdee K; Thongchote K; Krishnamra N
    Can J Physiol Pharmacol; 2008 May; 86(5):240-8. PubMed ID: 18432284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adiponectin regulates the expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand in human osteoblast].
    Zhang XM; Xie H; Yuan LQ; Luo XH; Liao EY
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1562-5. PubMed ID: 18956641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoclast-osteoblast communication.
    Matsuo K; Irie N
    Arch Biochem Biophys; 2008 May; 473(2):201-9. PubMed ID: 18406338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells.
    Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F
    J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
    Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y
    J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway.
    Chamoux E; Houde N; L'Eriger K; Roux S
    J Cell Physiol; 2008 Aug; 216(2):536-42. PubMed ID: 18338379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoblasts and bone formation.
    Caetano-Lopes J; Canhão H; Fonseca JE
    Acta Reumatol Port; 2007; 32(2):103-10. PubMed ID: 17572649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium butyrate stimulates mineralized nodule formation and osteoprotegerin expression by human osteoblasts.
    Katono T; Kawato T; Tanabe N; Suzuki N; Iida T; Morozumi A; Ochiai K; Maeno M
    Arch Oral Biol; 2008 Oct; 53(10):903-9. PubMed ID: 18406397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
    Knowles HJ; Athanasou NA
    J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of the cross-talk between macrophages and osteoblasts by titanium-based particles.
    Vallés G; Gil-Garay E; Munuera L; Vilaboa N
    Biomaterials; 2008 May; 29(15):2326-35. PubMed ID: 18313744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct and indirect estrogen actions on osteoblasts and osteoclasts.
    Zallone A
    Ann N Y Acad Sci; 2006 Apr; 1068():173-9. PubMed ID: 16831916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor activator of nuclear factor-kappa B ligand induces osteoclast formation in RAW 264.7 macrophage cells via augmented production of macrophage-colony-stimulating factor.
    Islam S; Hassan F; Tumurkhuu G; Dagvadorj J; Koide N; Naiki Y; Yoshida T; Yokochi T
    Microbiol Immunol; 2008 Dec; 52(12):585-90. PubMed ID: 19120972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Regulation of receptor activator of nuclear factor kappaB ligand and osteoprotegerin expression by prostaglandin E2 in osteoblastic-like cells].
    Wang BL; Zheng F; Qiu MC
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1992-6. PubMed ID: 19062743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow adipocytes support dexamethasone-induced osteoclast differentiation.
    Hozumi A; Osaki M; Goto H; Sakamoto K; Inokuchi S; Shindo H
    Biochem Biophys Res Commun; 2009 May; 382(4):780-4. PubMed ID: 19324007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct effects of osteoprotegerin on human bone cell metabolism.
    Grundt A; Grafe IA; Liegibel U; Sommer U; Nawroth P; Kasperk C
    Biochem Biophys Res Commun; 2009 Nov; 389(3):550-5. PubMed ID: 19748486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.
    Yang J; Park OJ; Lee YJ; Jung HM; Woo KM; Choi Y
    Eur J Immunol; 2008 Jun; 38(6):1598-609. PubMed ID: 18421790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inhibitory effects of macrolide antibiotics on bone remodeling in chronic rhinosinusitis.
    Park CS; Park YS; Park YJ; Cho JH; Kang JM; Kim SY
    Otolaryngol Head Neck Surg; 2007 Aug; 137(2):274-9. PubMed ID: 17666255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.